文献速递垂体与肾上腺疾病性腺与生殖内分泌

产前泼尼松(龙)与地塞米松对胎儿、新生儿及儿童结局安全性的系统综述

Safety of Antenatal Predniso(lo)ne and Dexamethasone on Fetal, Neonatal and Childhood Outcomes: A Systematic Review.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

该系统综述检索至2022年8月的文献,纳入15项研究,评估产前长期使用泼尼松(龙)或地塞米松对胎儿、新生儿及儿童期的不良反应。泼尼松(龙)可能与较低胎龄相关,但与流产、死产、先天畸形、血压或低血糖等无关联;地塞米松与流产和死产风险增加相关,16岁起与胰岛素分泌紊乱及血糖、胆固醇升高相关。基于有限证据,泼尼松(龙)短期和长期副作用可能少于地塞米松。

要点

  • 产前泼尼松(龙)可能与较低胎龄相关,但与流产、死产、先天畸形无关联。
  • 产前地塞米松与流产和死产风险增加相关,16岁起与胰岛素分泌紊乱及血糖、胆固醇升高相关。
  • 产前泼尼松(龙)剂量至每日10 mg时,新生儿副作用风险极小。

核心结论

  • 基于有限证据,泼尼松(龙)短期和长期副作用可能少于地塞米松。
  • 现有文献显示产前泼尼松(龙)剂量至每日10 mg时新生儿副作用风险极小。

研究设计与样本

  • 在PubMed/MEDLINE和Embase检索至2022年8月,使用预设关键词和医学主题词。
  • 纳入标准为在人类中评估至少一个孕期长期产前使用泼尼松(龙)和地塞米松对胎儿期、新生儿期和儿童期副作用的研究。
  • 共纳入15项研究,另通过参考文献补充7条记录。

主要发现

  • 产前泼尼松(龙)使用可能与较低胎龄相关,但与流产和死产、先天畸形、出生时血压差异或低血糖、低骨量、青春期前长期皮质醇和可的松升高或高血压无关联。
  • 产前地塞米松使用与流产和死产风险增加相关,16岁起与胰岛素分泌紊乱及血糖和胆固醇水平升高相关。

局限性

  • 由于伦理考虑,孕妇中泼尼松龙和地塞米松的产前剂量探索有限,导致知识空白。
  • 基于有限的证据发现,泼尼松(龙)可能副作用较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Due to ethical considerations, antenatal dose finding for prednisolone and dexamethasone in pregnant women is limited, leading to a knowledge gap. OBJECTIVE: In order to guide the clinician in weighing benefits vs risks, the aim is to systematically review the current literature on the side effects of antenatal predniso(lo)ne and dexamethasone use on the fetus, newborn, and (pre)pubertal child. EVIDENCE ACQUISITION: The search was performed in PubMed/MEDLINE and Embase using prespecified keywords and Medical Subject Headings. This systematic review investigated studies published until August 2022, with the following inclusion criteria: studies were conducted in humans and assessed side effects of long-term antenatal predniso(lo)ne and dexamethasone use during at least one of the trimesters on the child during the fetal period, neonatal phase, and during childhood. EVIDENCE SYNTHESIS: In total, 328 papers in PubMed and 193 in Embase were identified. Fifteen studies were eligible for inclusion. Seven records were added through references. Antenatal predniso(lo)ne use may be associated with lower gestational age, but was not associated with miscarriages and stillbirths, congenital abnormalities, differences in blood pressure or low blood glucose levels at birth, or with low bone mass, long-term elevated cortisol and cortisone, or high blood pressure at prepubertal age. Increased risks of antenatal dexamethasone use include association with miscarriages and stillbirths, and from age 16 years, associations with disturbed insulin secretion and higher glucose and cholesterol levels. CONCLUSIONS: Based on the limited evidence found, predniso(lo)ne may have less side effects compared with dexamethasone in short- and long-term outcomes. Current literature shows minimal risk of side effects in the newborn from administration of a prenatal predniso(lo)ne dose of up to 10 mg per day.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Slob EMA, Termote JUM, Nijkamp JW, et al. Safety of Antenatal Predniso(lo)ne and Dexamethasone on Fetal, Neonatal and Childhood Outcomes: A Systematic Review. J Clin Endocrinol Metab. 2024. PMID: 37715964. doi:10.1210/clinem/dgad547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。